crizotinib resistance in alk nsclc
Published 7 years ago • 771 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
4:38
alta ii: brigatinib in crizotinib-resistant alk nsclc
-
7:21
ceritinib in crizotinib-resistant nsclc
-
1:21
dr. shaw on crizotinib resistance in alk-positive lung cancer
-
7:02
crizotinib for alk-rearranged nsclc
-
1:22
dr. crinò on crizotinib in alk nsclc
-
5:52
ceritinib and alectinib in relapsed alk nsclc
-
4:38
patterns of progression on crizotinib for alk nsclc
-
6:04
case study: progression on alk inhibitors in nsclc
-
0:44
dr. mark kris discusses crizotinib for patients with alk-positive lung cancer
-
1:09
dr. camidge on crizotinib as a ros1 inhibitor in nsclc
-
1:57
dr. shaw on sequencing strategies in alk-positive nsclc
-
3:59
alectinib in alk-mutated nsclc
-
2:52
understanding acquired resistance in alk lung cancer
-
1:11
dr. salgia on crizotinib and other tkis in alk-positive nsclc
-
5:28
crown study: lorlatinib vs crizotinib in 1l nsclc
-
2:48
targeted therapy resistance mechanisms in alk nsclc
-
3:34
alk-positive nsclc: the role of treatment selection and sequencing
-
1:05
dr. west discusses crizotinib in alk-nsclc trial results
-
2:00
ceritinib and other second generation alk inhibitors for acquired resistance in alk-positive nsclc